Download 230 part 6

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Major metabolites of benzo[a]pyrene by MFO system
O
OH
O
H
H
HO
H OH
H
9,10-DHDO
9,10-oxide
O
1,6-Q
1-OH
O
11
12
1
2
10
3
9
8
O
7
OH
6,12-Q
H
H
4
5
6
benzo[a]pyrene
OH
HO
H
O
3,6-Q
H
4,5-DHDO
4,5-oxide
6-OH
O
HO
O
OH
H
3-OH*
H
O
H
H OH
7,8-DHDO
7,8-oxide
7-OH, 9-OH, 12-OH and the 4,5-Q have also
been reported
O
H
H
HO
HH
OH
diolepoxide
Arene oxide  phenol rearrangement
OH
H
O
H
OH
H
O
H
Stereochemistry of hydration by epoxide hydrolase
H
HO
O
H
H
OH
H
BP diolepoxide stereo isomers
H
HO
HO H
_ -7,8-dihydrodiol
(+)
H
O
H
H
H
HO
HO H
O
H
H
HO
HO H
_ -syn
(+)
_ -anti
(+)
(+)-anti: 7R,8S,9S,10R-BPDE
R, S CONVENTION
A
D
B
C
A>B>C
S
A>C>B
R
Lowest priority atom oriented towards rear, direction of
rotation is determined on the front face. Priority is assigned
by atomic number; when atoms are of equal atomic number,
the atoms bonded to the atoms under consideration are
considered.
Adducts of anti-BPDE with exocyclic amino groups of nucleobases
Heavy lines show the aromatic π-system
conjugated with, and stabilizing the incipient positive
charge resulting from attack at epoxide ring. This
situation favors addition adjacent to aromatic ring.
.N. H
+
2
O
-
N
d R
N
O
H N
d R
N
H N
N
N
N
H
N
H N
H
H
O H
H
O H
H
O H
H
O H
H
O H
H
O H
(+)-trans-anti--BPDE:N2-dGuo adduct at primer-template
junction
5'
Oxidized
angular
ring
Distal
end of
pyrene
system
adduct of (-)-trans-anti-BPDE with N6-dAdo: opposite dThyd from N-Ras fragment
5 face of
dAdo
Looking down helix axis
Looking perpendicular to
helix axis
cis adduct of (+)-anti-BPDE at N6 of dAdo
5 face of
dAdo
(-)-trans-anti-5-methylchrysene:dGuo
adduct at the hindered bay region
5'
3'
1
2
3
4
5 CH3
(+)-trans-anti-benzo[g]chrysene:dAdo
Inset: benzo[g]chrysene skeleton
R,S-trans-anti-benzo[c]phenanthrene:dGuo
S
R
benzo[ c]phenanthrene
classical intercalation
5-insertion
S-trans-anti-B[c]Ph
1(S)
5…C[G*]C…
normal duplex
classical intercalation
3-insertion
R-trans-anti-B[c]Ph
1(R)
5…C[G*]C…
normal duplex
BAY REGION THEORY
If a PAH has a bay region and shows genotoxic activity, the ultimate
active metabolite will be the bay region diolepoxide.
d
O
Nu
transition state for opening of bay region epoxide
heavy lines indicate the aromatic p-aromatic system
Aflatoxin B1 activation
O
O
O
2
O 1
O
3
O
9
5
O
O
7
O
O
4 OCH3
O
8
OCH3
endo (minor)
human
CYP3A4
6
O
O
aflatoxin B 1
AFB1
O
OCH3
O
O
Carcinogenic potency determined by:
O
1. Intrinsic activity of ultimate active metabolite
2. Proportion of metabolic pathway leading to
ultimate active metabolite
exo (major)
AFB1-8,9-oxide
Albumin
lysine
lysine
lysine
Reactions of AFB1-dGuo adduct
O
O
O
OCH3
HO
H
H
HO
O
O
hydrolysis
O
O
O
O
N
HN
H2N
HO
H
H
N
OCH3
O
O
N
depurination
AFB1-FAPy dGuo adduct
N9
N7
Vinyl chloride activation
ETHENO ( ADDUCTS FROM VINYL CHLORIDE
O
O
N
HN
N
N
N
N
N
N
N2,3-dGuo
N
N
1,N2-dGuo
N
N
N
N
N
N
N
O
3,N4-dCyd
1,N6-dAdo
N7-ADDUCT
O
O
H2C CH
N+
N
N
HN
H2N
N
N7-(2-oxoethyl)-dGuo
ACTIVATION OF DIMETHYLNITROSAMINE
GENERAL
STRUCTURE
R
N N
H3C
N N O
H3C
dimethylnitrosamine
(DMN)
O
R'
C-hydroxylation
by MFO
HOH2C
N N O
H3C
non-enzymatic
H
N N O
H3C
monomethyl
nitrosamine
+
N N OH
H3C
azotic acid
CH2O
H3C+ + N 2 + HO -
Activation of 2-AAF (general for amines)
other amines of commercial
importance
N H
2
2 - a m in o n a p h th a le n e
 - n a p h th y la m in e
H
2
N
N H
2
4 , 4 '- a m in o b ip h e n y l
C l
H
2
N
C l
C H
2
N H
2
4 , 4 '- d ia m in o - 3 , 3 '- d ic h lo r o d ip h e n y lm e t h a n e
m e th y le n e b is ( o - c h lo r o a n ilin e )
M O C A
Nitrenium ion adducts
O
NH
NH
2
N
N
N
dR
NH
O
NH
C8 adduct of AAF
H 2N
NH
N
N
C1 adduct of AAF
N
dR
O
NH
NH
2
N
N
N
NH
dR
C8 adduct 1-aminopyrene
Activation of nitroaromatics-multiple pathways,
MFO and nitroreductase
Other important
environmental nitroPAH
H N OCOCH3
Pathway A
Pathway B
R
Pathway C
Pathway D
1
OAT
NO
NO2
NH+
H N OH
2
3
reduce
R
R
reduce
R
P450
nitrenium ion
P450 reduce
NH2
NO2
binding to DNA
R
R
NO2
3-nitrofluoranthene
R
O
NAT
H N COCH3
NO2
NO2
2-nitrofluoranthene
R
R
binding to DNA
P450
-
O
+
carbonium ion
+ N COCH3
HO N COCH3
R
R
binding to DNA
R = -OH
OAT =O-acetyltransferase
NAT =N-acetyltransferase
nitrenium ion
CH3COO N COCH3
OAT
R
Deamination via diazotization reaction
Deamination by bisulfite reaction
Direct acting
mutagens
O
H2N
CH3
N
NO
H 2O
N-methyl- N-nitrosourea
(MNU)
NH
HN
O2N
CH3
N
NO
O
CH3
HN
NO
+
methylnitrosamine
H2O
N-methyl- N'-nitro-N-nitrosoguanidine
(MNNG)
H2N
OH
carbamic acid
O
CH3
HN
NO
+
methylnitrosamine
O2NN
NH2
H
nitrourea
O
H3C S OCH3
O
H3C
O
methylmethanesulfonate
O
H3CO S OCH3
O
dimethyl sulfate
propylene oxide
O
O
H2C CH2
-propiolactone
CH2CH2Cl
O
O
H2C
P
CH2
ethylene oxide
N
N CH CH Cl
2
2
O
cyclophosphamide
Related documents